Sapient Bioanalytics Launches Mapping Platform for Cancer Cells (opens original article in a new tab)

Sapient Bioanalytics launched a mass spectrometry-based platform to map proteins in cancer cells, aiming to improve targeted cancer therapies by providing detailed molecular insights.

• Sapient Bioanalytics developed a Tumor Protein Mapping Platform using mass spectrometry to measure proteins in cancer samples.
• The platform enables comprehensive analysis of proteins, DNA mutations, and RNA levels to identify optimal drug targets.
• Sapient differentiates itself by offering specialized, custom assays for biopharmaceutical companies and startups.